image: Marit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleagues will now be tested in the USA on patients ...
To trip up fast-proliferating cancer cells, try throwing a wrench in their proliferation machinery, the aptly named proliferating cell nuclear antigen (PCNA). Wielding a new kind of wrench, a ...
“This finding implicates that targeting PCNA/AR interaction could be an innovative strategy for therapy against CRPC.” In this study, authors Shan Lu and Zhongyun Dong from the University of ...